New  ||| S:0 E:4 ||| NNP
TNM  ||| S:4 E:8 ||| NNP
classification  ||| S:8 E:23 ||| NN
of  ||| S:23 E:26 ||| IN
malignant  ||| S:26 E:36 ||| JJ
lung  ||| S:36 E:41 ||| NN
tumors  ||| S:41 E:48 ||| VBD
2009  ||| S:48 E:53 ||| CD
from  ||| S:53 E:58 ||| IN
a  ||| S:58 E:60 ||| DT
pathology  ||| S:60 E:70 ||| JJ
perspective  ||| S:70 E:82 ||| NN
Based  ||| S:82 E:88 ||| VBN
on  ||| S:88 E:91 ||| IN
the  ||| S:91 E:95 ||| DT
IASLC  ||| S:95 E:101 ||| NNP
multicenter  ||| S:101 E:113 ||| NN
data  ||| S:113 E:118 ||| NNS
collected  ||| S:118 E:128 ||| VBD
worldwide  ||| S:128 E:138 ||| VBN
on  ||| S:138 E:141 ||| IN
81495  ||| S:141 E:147 ||| CD
patients  ||| S:147 E:156 ||| NNS
diagnosed  ||| S:156 E:166 ||| VBN
or  ||| S:166 E:169 ||| CC
registered  ||| S:169 E:180 ||| VBN
with  ||| S:180 E:185 ||| IN
lung  ||| S:185 E:190 ||| NN
cancer  ||| S:190 E:197 ||| NN
between  ||| S:197 E:205 ||| IN
1990  ||| S:205 E:210 ||| CD
and  ||| S:210 E:214 ||| CC
2000 ||| S:214 E:218 ||| CD
,  ||| S:218 E:220 ||| ,
the  ||| S:220 E:224 ||| DT
T ||| S:224 E:225 ||| NN
,  ||| S:225 E:227 ||| ,
N ||| S:227 E:228 ||| NNP
,  ||| S:228 E:230 ||| ,
and  ||| S:230 E:234 ||| CC
M  ||| S:234 E:236 ||| NNP
descriptors  ||| S:236 E:248 ||| NN
were  ||| S:248 E:253 ||| VBD
analyzed  ||| S:253 E:262 ||| VBN
and  ||| S:262 E:266 ||| CC
recommendations  ||| S:266 E:282 ||| NNS
for  ||| S:282 E:286 ||| IN
changes  ||| S:286 E:294 ||| NNS
in  ||| S:294 E:297 ||| IN
the  ||| S:297 E:301 ||| DT
seventh  ||| S:301 E:309 ||| JJ
edition  ||| S:309 E:317 ||| NN
of  ||| S:317 E:320 ||| IN
the  ||| S:320 E:324 ||| DT
TNM  ||| S:324 E:328 ||| NNP
classification  ||| S:328 E:343 ||| NN
were  ||| S:343 E:348 ||| VBD
proposed  ||| S:348 E:357 ||| VBN
on  ||| S:357 E:360 ||| IN
the  ||| S:360 E:364 ||| DT
basis  ||| S:364 E:370 ||| NN
of  ||| S:370 E:373 ||| IN
differences  ||| S:373 E:385 ||| NNS
in  ||| S:385 E:388 ||| IN
survival ||| S:388 E:396 ||| NN
.  ||| S:396 E:398 ||| .
This  ||| S:398 E:403 ||| DT
new  ||| S:403 E:407 ||| JJ
TNM  ||| S:407 E:411 ||| NNP
classification  ||| S:411 E:426 ||| NN
replaces  ||| S:426 E:435 ||| VBZ
the  ||| S:435 E:439 ||| DT
old  ||| S:439 E:443 ||| JJ
UICC  ||| S:443 E:448 ||| NNP
classification  ||| S:448 E:463 ||| NN
and  ||| S:463 E:467 ||| CC
the  ||| S:467 E:471 ||| DT
staging  ||| S:471 E:479 ||| NN
system  ||| S:479 E:486 ||| NN
according  ||| S:486 E:496 ||| VBG
to  ||| S:496 E:499 ||| TO
C.  ||| S:499 E:502 ||| NNP
Mountain  ||| S:502 E:511 ||| NNP
1997 ||| S:511 E:515 ||| CD
.  ||| S:515 E:517 ||| .
The  ||| S:517 E:521 ||| DT
changes  ||| S:521 E:529 ||| NNS
principally  ||| S:529 E:541 ||| RB
affect  ||| S:541 E:548 ||| VB
the  ||| S:548 E:552 ||| DT
T  ||| S:552 E:554 ||| NN
and  ||| S:554 E:558 ||| CC
M  ||| S:558 E:560 ||| NNP
classifications ||| S:560 E:575 ||| NNS
.  ||| S:575 E:577 ||| .
For  ||| S:577 E:581 ||| IN
the  ||| S:581 E:585 ||| DT
T  ||| S:585 E:587 ||| NN
component ||| S:587 E:596 ||| NN
,  ||| S:596 E:598 ||| ,
tumor  ||| S:598 E:604 ||| NN
size  ||| S:604 E:609 ||| NN
was  ||| S:609 E:613 ||| VBD
found  ||| S:613 E:619 ||| VBN
to  ||| S:619 E:622 ||| TO
have  ||| S:622 E:627 ||| VB
prognostic  ||| S:627 E:638 ||| JJ
relevance  ||| S:638 E:648 ||| NN
and  ||| S:648 E:652 ||| CC
its  ||| S:652 E:656 ||| PRP$
analysis  ||| S:656 E:665 ||| NN
led  ||| S:665 E:669 ||| VBD
to  ||| S:669 E:672 ||| TO
recommendations  ||| S:672 E:688 ||| NNS
to  ||| S:688 E:691 ||| TO
subclassify  ||| S:691 E:703 ||| CD
T1  ||| S:703 E:706 ||| CD
into  ||| S:706 E:711 ||| IN
T1a  ||| S:711 E:715 ||| NNP
and  ||| S:715 E:719 ||| CC
T1b ||| S:719 E:722 ||| NNP
,  ||| S:722 E:724 ||| ,
and  ||| S:724 E:728 ||| CC
T2  ||| S:728 E:731 ||| CD
tumors  ||| S:731 E:738 ||| NNS
into  ||| S:738 E:743 ||| IN
T2a  ||| S:743 E:747 ||| NNP
and  ||| S:747 E:751 ||| CC
T2b  ||| S:751 E:755 ||| NNP
and  ||| S:755 E:759 ||| CC
to  ||| S:759 E:762 ||| TO
reclassify  ||| S:762 E:773 ||| CD
T2  ||| S:773 E:776 ||| CD
tumor ||| S:776 E:781 ||| CD
> ||| S:781 E:782 ||| CD
7  ||| S:782 E:784 ||| CD
cm  ||| S:784 E:787 ||| NN
into  ||| S:787 E:792 ||| IN
T3  ||| S:792 E:795 ||| CD
tumors ||| S:795 E:801 ||| NNS
.  ||| S:801 E:803 ||| .
In  ||| S:803 E:806 ||| IN
the  ||| S:806 E:810 ||| DT
M  ||| S:810 E:812 ||| NNP
category ||| S:812 E:820 ||| NN
,  ||| S:820 E:822 ||| ,
M1  ||| S:822 E:825 ||| NNP
was  ||| S:825 E:829 ||| VBD
recommended  ||| S:829 E:841 ||| VBN
to  ||| S:841 E:844 ||| TO
be  ||| S:844 E:847 ||| VB
subclassified  ||| S:847 E:861 ||| VBN
into  ||| S:861 E:866 ||| IN
M1a  ||| S:866 E:870 ||| NNP
( ||| S:870 E:871 ||| -LRB-
contralateral  ||| S:871 E:885 ||| JJ
lung  ||| S:885 E:890 ||| NN
nodules  ||| S:890 E:898 ||| NNS
and  ||| S:898 E:902 ||| CC
pleural  ||| S:902 E:910 ||| JJ
dissemination ||| S:910 E:923 ||| NN
)  ||| S:923 E:925 ||| -RRB-
and  ||| S:925 E:929 ||| CC
M1b  ||| S:929 E:933 ||| NNP
( ||| S:933 E:934 ||| -LRB-
distant  ||| S:934 E:942 ||| JJ
metastasis ||| S:942 E:952 ||| NN
) ||| S:952 E:953 ||| -RRB-
.  ||| S:953 E:955 ||| .
There  ||| S:955 E:961 ||| EX
is  ||| S:961 E:964 ||| VBZ
no  ||| S:964 E:967 ||| DT
change  ||| S:967 E:974 ||| NN
in  ||| S:974 E:977 ||| IN
the  ||| S:977 E:981 ||| DT
N  ||| S:981 E:983 ||| NNP
category ||| S:983 E:991 ||| NN
.  ||| S:991 E:993 ||| .
The  ||| S:993 E:997 ||| DT
proposed  ||| S:997 E:1006 ||| JJ
changes  ||| S:1006 E:1014 ||| NNS
for  ||| S:1014 E:1018 ||| IN
the  ||| S:1018 E:1022 ||| DT
new  ||| S:1022 E:1026 ||| JJ
stage  ||| S:1026 E:1032 ||| NN
grouping  ||| S:1032 E:1041 ||| NNS
are  ||| S:1041 E:1045 ||| VBP
to  ||| S:1045 E:1048 ||| TO
upstage  ||| S:1048 E:1056 ||| CD
T2b  ||| S:1056 E:1060 ||| CD
N0  ||| S:1060 E:1063 ||| CD
M0  ||| S:1063 E:1066 ||| CD
from  ||| S:1066 E:1071 ||| IN
stage  ||| S:1071 E:1077 ||| NN
IB  ||| S:1077 E:1080 ||| NN
to  ||| S:1080 E:1083 ||| TO
stage  ||| S:1083 E:1089 ||| VB
IIA  ||| S:1089 E:1093 ||| NNP
and  ||| S:1093 E:1097 ||| CC
to  ||| S:1097 E:1100 ||| TO
downstage  ||| S:1100 E:1110 ||| CD
T2a  ||| S:1110 E:1114 ||| CD
N1  ||| S:1114 E:1117 ||| CD
M0  ||| S:1117 E:1120 ||| CD
from  ||| S:1120 E:1125 ||| IN
stage  ||| S:1125 E:1131 ||| NN
IIB  ||| S:1131 E:1135 ||| NN
to  ||| S:1135 E:1138 ||| TO
stage  ||| S:1138 E:1144 ||| VB
IIA  ||| S:1144 E:1148 ||| NNP
and  ||| S:1148 E:1152 ||| CC
T4  ||| S:1152 E:1155 ||| CD
N0-N1  ||| S:1155 E:1161 ||| CD
M0  ||| S:1161 E:1164 ||| CD
from  ||| S:1164 E:1169 ||| IN
stage  ||| S:1169 E:1175 ||| NN
IIIB  ||| S:1175 E:1180 ||| NN
to  ||| S:1180 E:1183 ||| TO
stage  ||| S:1183 E:1189 ||| VB
IIIA ||| S:1189 E:1193 ||| NNP
.  ||| S:1193 E:1195 ||| .
The  ||| S:1195 E:1199 ||| DT
particulars  ||| S:1199 E:1211 ||| NN
of  ||| S:1211 E:1214 ||| IN
the  ||| S:1214 E:1218 ||| DT
new  ||| S:1218 E:1222 ||| JJ
classification  ||| S:1222 E:1237 ||| NNS
are  ||| S:1237 E:1241 ||| VBP
discussed  ||| S:1241 E:1251 ||| VBN
in  ||| S:1251 E:1254 ||| IN
the  ||| S:1254 E:1258 ||| DT
context  ||| S:1258 E:1266 ||| NN
of  ||| S:1266 E:1269 ||| IN
practice-relevant  ||| S:1269 E:1287 ||| JJ
aspects  ||| S:1287 E:1295 ||| NNS
from  ||| S:1295 E:1300 ||| IN
a  ||| S:1300 E:1302 ||| DT
pathology  ||| S:1302 E:1312 ||| JJ
perspective  ||| S:1312 E:1324 ||| NN
view ||| S:1324 E:1328 ||| NN
.  ||| S:1328 E:1330 ||| .
